SEC Form 4 · accession 0001746473-26-000100
PLIANT THERAPEUTICS, INC. · PLRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Hoyoung Huh
Director
Period of report
Jun 11, 2026
Accepted (ET)
Jun 12, 2026 · 5:00 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001746473
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.14 | Jun 11, 2026 | A | 70,000 | A | — | Jun 11, 2036 | Common Stock | 70,000 | 70,000 | D |
Explanation of responses
- F125% of the shares subject to such option vest and become exercisable on October 1, 2026, January 1, 2027, and April 1, 2027, respectively, and the remaining 25% of the shares subject to such option vest and become exercisable on the earlier of (i) the one-year anniversary of the June 11, 2026 grant date or (ii) the next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer as a Director through each such date or, if earlier, such annual meeting.